Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$242.49 - $301.46 $90,206 - $112,143
-372 Reduced 15.49%
2,030 $499,000
Q2 2022

Aug 15, 2022

BUY
$224.73 - $338.64 $265,855 - $400,611
1,183 Added 97.05%
2,402 $595,000
Q1 2022

May 16, 2022

BUY
$277.25 - $366.29 $6,654 - $8,790
24 Added 2.01%
1,219 $404,000
Q3 2021

Nov 15, 2021

SELL
$310.19 - $376.2 $60,176 - $72,982
-194 Reduced 13.97%
1,195 $389,000
Q2 2021

Aug 16, 2021

SELL
$262.71 - $351.17 $59,897 - $80,066
-228 Reduced 14.1%
1,389 $434,000
Q1 2021

May 14, 2021

BUY
$285.92 - $355.13 $70,908 - $88,072
248 Added 18.12%
1,617 $515,000
Q4 2020

Feb 12, 2021

BUY
$251.88 - $324.2 $10,830 - $13,940
43 Added 3.24%
1,369 $444,000
Q3 2020

Nov 13, 2020

SELL
$255.22 - $317.0 $67,633 - $84,005
-265 Reduced 16.66%
1,326 $367,000
Q2 2020

Aug 13, 2020

BUY
$141.4 - $257.09 $224,967 - $409,030
1,591 New
1,591 $384,000
Q3 2019

Nov 14, 2019

SELL
$175.89 - $279.23 $713,409 - $1.13 Million
-4,056 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$250.96 - $284.94 $1.02 Million - $1.16 Million
4,056 New
4,056 $1.06 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.